<--- Back to Details
First PageDocument Content
Pharmaceutical sciences / Medicine / Clinical research / Pharmacology / Pharmacovigilance / EudraPharm / EudraVigilance / Pharmaceuticals policy / Drug safety / Health
Date: 2012-02-09 06:17:14
Pharmaceutical sciences
Medicine
Clinical research
Pharmacology
Pharmacovigilance
EudraPharm
EudraVigilance
Pharmaceuticals policy
Drug safety
Health

Microsoft Word - Stakeholders Information_May2009_rev_3.doc

Add to Reading List

Source URL: www.hma.eu

Download Document from Source Website

File Size: 35,14 KB

Share Document on Facebook

Similar Documents

Curriculum Vitae Toshifumi Tatsumi Graduate School of Pharmaceutical Sciences, Prof. Kanai Group The University of TokyoHongo, Bunkyo-ku, Tokyo, japan Tel: (+

DocID: 1vqFn - View Document

JPPT Review Article Developmental Pharmacokinetics in Pediatric Populations Hong Lu, PhD and Sara Rosenbaum, PhD Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, Rhode Island

DocID: 1vmzU - View Document

Institute of Pharmaceutical Sciences Institut für Pharmazeutische Wissenschaften Institute Management

DocID: 1veuM - View Document

Faculty Position in the Graduate School of Pharmaceutical Sciences, Osaka University Outline We are now inviting applications for an Associate Professor (Lecturer) (fulltime, no fixed term) in Laboratory of Bio-Funciton

DocID: 1vesi - View Document

Invites you for “International Conference on the use of National Medicine Policy and Biostatistics in Pharmaceutical Sciences” th

DocID: 1vdv9 - View Document